- Home
- ITCI
as 03-13-2025 12:38pm EST
Intra-Cellular Therapies Inc is a biopharmaceutical company that develops novel drugs for treating diseases of the central nervous system. The company is focused on the delivery and clinical development of small-molecule drugs that address needs in neuropsychiatric and neurological disorders. Intra-Cellular maintains proprietary chemistry platforms to develop drugs for neurodegenerative diseases. The company's business segment is discovering and developing drugs for the treatment of neurological and psychiatric disorders.
| Founded: | 2002 | Country: | United States |
| Employees: | N/A | City: | BEDMINSTER |
| Market Cap: | 13.5B | IPO Year: | N/A |
| Target Price: | $106.58 | AVG Volume (30 days): | 2.3M |
| Analyst Decision: | Buy | Number of Analysts: | 13 |
| Dividend Yield: | N/A | Dividend Payout Frequency: | N/A |
| EPS: | -0.72 | EPS Growth: | N/A |
| 52 Week Low/High: | $63.30 - $131.37 | Next Earning Date: | 05-06-2025 |
| Revenue: | $680,852,000 | Revenue Growth: | 46.62% |
| Revenue Growth (this year): | 40.64% | Revenue Growth (next year): | 58.53% |
Latest Intra-Cellular Therapies Inc. News
ITCI Breaking Stock News: Dive into ITCI Ticker-Specific Updates for Smart Investing
Insider Monkey
12 days ago
Intra-Cellular Therapies, Inc. (ITCI): Among the Best Psychedelic Stocks to Buy in 2025
Zacks
17 days ago
ITCI Q4 Loss Wider Than Expected, Revenues Top on Higher Caplyta Sales
MT Newswires
17 days ago
Mizuho Downgrades Intra-Cellular Therapies to Neutral From Outperform, Lowers Price Target to $132 From $140
Zacks
20 days ago
Intra-Cellular Therapies (ITCI) Reports Q4 Loss, Tops Revenue Estimates
Associated Press Finance
20 days ago
Intra-Cellular: Q4 Earnings Snapshot
MT Newswires
20 days ago
Intra-Cellular Therapies Q4 Net Loss Narrows, Revenue Rises
GlobeNewswire
20 days ago
Intra-Cellular Therapies Reports Fourth Quarter and Full-Year 2024 Financial Results
GuruFocus.com
a month ago
Steady M&A Deals to Begin 2025, Disappointing IPOs So Far
Compare ITCI vs Leading Stocks
Share on Social Networks:
Disclaimer
The information presented on this page, "ITCI Intra-Cellular Therapies Inc. - Stocks Price | History | Analysis", including historical data, forecasts, news, insider information, and predictions, is provided for educational purposes only. It should not be considered as financial advice or a recommendation to buy or sell any securities. Decisions regarding investments should be made only after careful consideration and consultation with a qualified financial advisor. We do not endorse or guarantee the accuracy or reliability of the information provided, and we disclaim any liability for financial losses incurred as a result of decisions made based on the information presented.